clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01677195 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2014-08-01 | |
P4135 | maximum age | 85 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 234 | |
P4844 | research intervention | calcium carbonate | Q23767 |
calcium oxalate | Q412399 | ||
P1813 | short name | RDMEACCS100 | |
P580 | start time | 2012-09-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | "Phase II, Reduction of Dietary Mycotoxin Exposure in Persons in Bexar County, Texas by Ingestion of ACCS100 Capsules Compared to Placebo." |
Search more.